Fewer middle-aged people are dying from cancer in the U.K. than at any point over the last 25 years, a new study from Cancer Research UK has revealed. The study showed that overall, mortality rates have dropped by 37% in men and by 33% in women over that span.
Scientists at Pennsylvania State University have successfully 3D-printed living human skin tissue directly into the open wounds of rats for the first time in history. This bioengineering milestone could pave the way for major developments in reconstructive surgery — or even human hair treatments. Current methods of skin and hair reconstruction — like skin grafts — often result in scars, meaning this discovery could lead to a more seamless treatment for humans.
MethaneSAT, developed by the Environmental Defense Fund in partnership with the New Zealand Space Agency, is the size of a washing machine and cost $88 million to build and launch. While part of its mission is to spot polluters, the other side of the coin is that it can verify that others are indeed managing those emissions in a responsible fashion. Stemming methane leaks is the fastest single way to curb the escalation of average global temperatures, according to The Guardian.
Scientists at Yale University adapted existing human cancer treatments to find a new version that could benefit both humans and dogs. After conducting multiple clinical trials involving over 300 dogs over the past eight years, the researchers say that their canine cancer vaccine has almost doubled the 12-month survival rate for dogs with some types of cancer.
Scientists at the University of Chicago have developed a new pacemaker that’s thinner than a human hair, wireless, and operated entirely by light from an optic fiber. The non-invasive device could help regulate heart activity or even stimulate neurons in a set pattern to treat symptoms of conditions like Parkinson’s.
Led by researchers from the University of Cambridge, a clinical trial examined the effectiveness of giving the immunotherapy drug infliximab earlier, as soon as possible after diagnosis. They employed what’s called a ‘top-down’ strategy, meaning the drug was given straight after diagnosis regardless of the patient’s symptom severity. They found that this early intervention significantly reduces complications of this often debilitating disease, including the need for surgery by a factor of 10.
Brain stem glioma, officially called diffuse intrinsic pontine glioma (DIPG), is rare and lethal, diagnosed in just 300 children annually in the United States. The two-year survival rate is 10%, and no drug is widely available for its treatment beyond radiotherapy. After the boy’s diagnosis, the family traveled to France to take part in a randomized controlled trial. He was randomly assigned the drug everolimus, which he took for more than 5 years with remarkable success.
Solar cell efficiency may get a bump from bumps. New research from Turkey’s Abdullah Gül University suggests that building tiny domes into the surface of organic solar cells could boost their efficiency by up to two-thirds, while capturing light from a wider angle.
A new hand-held portable device is not only extremely quick and easy to use but very cost effective, say scientists from the University of Florida and National Yang Ming Chiao Tung University in Taiwan. Compared to the costly alternatives of Mammograms, which expose women to radiation—or MRIs and ultrasounds which require expensive equipment—researchers called the device revolutionary.
Scientists at Queen Mary University of London have developed a drug to treat mesothelioma, a notoriously deadly and hard-to-treat cancer linked to asbestos, in the biggest breakthrough in two decades.
An international trial spanning five countries found that the new drug, ADI-PEG20, cuts off the tumor’s food supply and quadruples three-year survival rates. It is the first of its kind to be successfully combined with chemotherapy in 20 years.
